President update, October 2025

I begin this month with the sad news of two recent losses in our ESPE community. Professor Juliane Léger and Professor Lucia Ghizzoni were both warm, kind individuals who were regularly present at ESPE Annual Meetings. Their contributions and friendship will be deeply missed. We extend our heartfelt condolences to their families, friends, and colleagues.

As we enter the last quarter of the year, I would like to remind you all of the key dates and events that are still to come this year.

On the 4th November, our Corporate Liaison Board chair, Prof Mohamad Maghnie will take part in a joint webinar with ESE and Endo-Ern colleagues to discuss recent therapeutic perspectives for rare endocrine diseases. The panel will discuss if long-acting rhGH is an improvement over daily rhGH, whether Palopegteriparatide offers new perspectives for hypoparathyroid patients, and novel therapies in acromegaly. Register your place today.

We have several committee vacancies closing soon, including the position of Chair of Clinical Practice Committee, two Communications Committee Members, and one YES Group representative for the Communications Committee. Find details of all vacancies on the website, along with the role descriptions and details on how to apply. The deadline for each is the 7th November, so make sure to apply soon.

I am also delighted that our popular Winter School will be back again in March next year. Applications close on the 10th November, so make sure to submit your application to have the opportunity to join us in Riga, Latvia next year for this interactive learning experience.

If you know someone making an outstanding contribution to paediatric endocrinology, I urge you to consider nominating them for one of our prestigious ESPE awards. You can find full details on all six awards on the website along with nomination information – make sure to submit before the 10th December.

I would also like to remind readers that the deadline for the ESPE Research Unit Grant is coming up on the 15th December. This collaborative research grant is designed to foster and coordinate high-quality research by identifying key topics and supporting collaboration between physicians and scientists in the field of paediatric endocrinology.

Finally, I would like to ask readers to consider taking part in two open ESPE surveys:
If you are involved in paediatric obesity care, this survey will help ESPE and related organisations better understand clinical practices, training gaps, and multidisciplinary approaches.

We invite healthcare professionals involved in the care of patients with Turner Syndrome to complete this survey on transition care and help to shape the future of Turner Syndrome care. The questions explores current practices, challenges, and needs in transitioning patients from paediatric to adult care.

All the very best,

Mehul Dattani
ESPE President